Back to Trades
Grant4
Vera Therapeutics, Inc.
VERA
Total Value
$5.9M
Company Information
- Company Name
- Vera Therapeutics, Inc.
- Ticker Symbol
- VERA
- CIK
- 0001831828
Insider Information
- Name
- Fordyce Marshall
- Role
- Insider
- Location
- BRISBANE, CA
Filing Details
- Filing Date
- Feb 6, 2026
- Transaction Date
- Feb 4, 2026
- Accession Number
- 0001859453-26-000002
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Feb 4, 2026 | Class A Common Stock | 68,800 | — | Grant/Award | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Feb 4, 2026 | Derivative | 137,500 | $42.74 | Grant/Award | $5.9M |
Footnotes
- (F1)Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") granted under the Issuer's 2021 Equity Incentive Plan. One-fourth of the RSUs, rounded to the nearest whole share, vest on each of February 20, 2027, 2028, 2029 and 2030, subject to the Reporting Person's continuous service through each vesting date.
- (F2)Includes 623 shares of Class A Common Stock acquired under the Issuer's 2021 Employee Stock Purchase Plan on March 13, 2025.
- (F3)On November 19, 2025, the Reporting Person transferred 99,081 shares of the Issuer's Class A Common Stock to The Fordyce Revocable Trust (the "Trust") for no consideration. The Reporting Person is a trustee of the Trust.
- (F4)1/48th of the shares subject to the stock option will vest and become exercisable on March 4, 2026, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date.